Skip to main content
Caplight Logo









ReversingLabs

ReversingLabs

Private
Cambridge, MassachusettsCybersecurityhttps://reversinglabs.com

Last Round

Series B

Aug 5, 2021

Total Funding Raised

$81M

Company Overview

ReversingLabs operates in Cybersecurity and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in August 2021.

ReversingLabs is a cybersecurity company that provides advanced threat detection, malware analysis, and software supply chain security solutions for enterprises and government organizations.

Sector

Cybersecurity

Verticals

Application Security, Threat Intelligence, DevOps & Containers, Vulnerability Management

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ReversingLabs Comparables

Compare ReversingLabs with similar companies based on industry and business-model similarity.

ReversingLabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anchore
82%
Sonatype
82%
Ox Security
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ReversingLabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 5, 2021
Series ANov 29, 2017
SeedFeb 15, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Angiras Koorapaty

Chief Financial Officer

Executive Team

Saša Zdjelar

Chief Trust Officer (CTrO)

Executive Team

For institutional investors. Book with your work email.

ReversingLabs Investors

Notable investors and investment history

ReversingLabs investors
InvestorRounds
Forgepoint CapitalSeries B, Series A
PreludeSeries B
Prelude VenturesSeries B
Crosspoint Capital PartnersSeries B
In-Q-TelSeed
JPMorgan Chase & Co.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Participating in NATO CCDCOE's Locked Shields 2026 cyber defense exercise.

  • Apr 8, 2026

    Recognized for outstanding achievement in 'Software Supply Chain Security'.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • launchesOct 28, 2026

    ReversingLabs Inc. launches Spectra Assure Catalog in Massachusetts on Oct 28th '26, giving employees and IT teams a trusted place to find and download approved software, with availability now for Spectra Assure customers.

  • receives_awardOct 21, 2026

    On Oct 21st '26 in Massachusetts, Cyber Defense Magazine names ReversingLabs Inc.'s Spectra Assure platform a winner of the 2026 Top InfoSec Innovator Award for Cutting-Edge Software Supply Chain Security during CyberDefenseCon 2026.

  • launchesOct 21, 2026

    ReversingLabs Inc. announces the availability of Spectra Resolve, an AI-native desktop app for fixing open-source dependency issues, as a new Spectra Assure Community offering in Massachusetts on Oct 21st '26.

  • recognized_asOct 21, 2026

    On Oct 21st '26 in Massachusetts, ReversingLabs Inc. announces that its Spectra Assure platform is named a winner by Cyber Defense Magazine in the 2026 Top InfoSec Innovator Awards for Cutting-Edge Software Supply Chain Security.

  • recognized_asOct 8, 2026

    On Oct 8th '26 in Massachusetts, ReversingLabs Inc. announces that its Spectra Detect platform earns the Threat Detection Solution Provider of the Year title in the 2026 CyberSecurity Breakthrough Awards.

Book a demo to see all news

For institutional investors. Book with your work email.

ReversingLabs Filings

Explore SEC and related filing metadata, where available.

ReversingLabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ReversingLabs's valuation, stock price, and market status.

Is ReversingLabs a public or private company?

ReversingLabs is a private company.

What is the current stock price of ReversingLabs?

ReversingLabs is a private company, so its shares have no public market price. Caplight tracks ReversingLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ReversingLabs worth (valuation)?

Valuation information for ReversingLabs is not publicly available.

Can I buy ReversingLabs stock?

ReversingLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ReversingLabs's last funding round?

ReversingLabs's most recent funding round was Series B on August 5, 2021.

Who are the main investors in ReversingLabs?

Key investors in ReversingLabs include Forgepoint Capital, Crosspoint Capital Partners, JPMorgan Chase & Co..

Will ReversingLabs IPO soon?

No public IPO plans have been announced for ReversingLabs.

How can I track ReversingLabs secondary market activity?

Caplight tracks bids, offers, and trades in ReversingLabs's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range252
Year Founded2009
Last FundingAug 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?